Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiplatelet Drugs”

278 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 278 results

Post-approval studies (Phase 4)Study completedNCT01325935
What this trial is testing

Optimal Duration of DAPT Following Treatment With Endeavor (Zotarolimus-eluting Stent) in Real-world Japanese Patients

Who this might be right for
Coronary Artery Disease
Associations for Establishment of Evidence in Interventions 1,187
Large-scale testing (Phase 3)Study completedNCT02166008
What this trial is testing

Cytoprotective Agent and Peptic Ulcer in Dual Antiplatelet :RCT

Who this might be right for
Gastric Ulcer Induced by Anti-platelet AgentDuodenal Ulcer Induced by Anti-platelet Agent
King Chulalongkorn Memorial Hospital 142
Post-approval studies (Phase 4)Study completedNCT04418479
What this trial is testing

SMart Angioplasty Research Team: CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 3

Who this might be right for
Coronary Artery Disease
Joo-Yong Hahn 5,506
Not applicableStudy completedNCT03197298
What this trial is testing

Change of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome

Who this might be right for
Acute Coronary SyndromePercutaneous Coronary InterventionDrug-Eluting Stents
Thorax Centrum Twente 2,062
Not applicableLooking for participantsNCT06298682
What this trial is testing

Characterization of Exosomes Platelets-released

Who this might be right for
Platelet Thrombus
Centro Cardiologico Monzino 175
Not applicableUnknownNCT03012906
What this trial is testing

Registry of the Combination of Antiplatelet Agents and Anticoagulant in Atrial Fibrillation Patients With a CHA2DS2VASc Score >1 Undergoing Percutaneous Coronary Interventions

Who this might be right for
Percutaneous Coronary Intervention
Assistance Publique Hopitaux De Marseille 500
Post-approval studies (Phase 4)Study completedNCT01051206
What this trial is testing

The Effect of 6% Hydroxyethyl Starch 130/0.4 on Blood Loss and Coagulation in Patients Medicated With Antiplatelet Agents Prior to Off-Pump Coronary Bypass Graft Surgery

Who this might be right for
Coronary Artery Occlusive Disease
Yonsei University 106
Post-approval studies (Phase 4)Study completedNCT01369186
What this trial is testing

Drug Drug Interactions of Aspirin and P2Y12-inhibitors

Who this might be right for
Drug Interaction PotentiationMyocardial Infarction
Medical University of Vienna 95
Post-approval studies (Phase 4)UnknownNCT02792712
What this trial is testing

Ticagrelor Versus Clopidogrel in Myocardial Salvage in Patients With STEMI Undergoing Primary PCI

Who this might be right for
Acute Coronary Syndrome
Taipei Veterans General Hospital, Taiwan 200
Not applicableStudy completedNCT05053828
What this trial is testing

Type 2 Diabetes With Antiplatelet Drugs

Who this might be right for
Type2 DiabetesAntiplatelet DrugsMyocardial Infarction+1 more
Tabula Rasa HealthCare 173,464
Not applicableStudy completedNCT06881901
What this trial is testing

Antiplatelet Strategy for CCS Patients Undergoing CABG

Who this might be right for
Chronic Coronary SyndromeCoronary Artery Bypass Graft CABG
Samsung Medical Center 29,898
Post-approval studies (Phase 4)Looking for participantsNCT05418556
What this trial is testing

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Who this might be right for
Coronary Artery Disease
Asan Medical Center 3,944
Not applicableEnded earlyNCT02840929
What this trial is testing

Effect of Second-look Endoscopy on Peptic Ulcer Rebleeding in Patients With Early Resumption of Antiplatelet Agents

Who this might be right for
OGDGastric Ulcer Induced by Anti-platelet AgentDuodenal Ulcer Induced by Anti-platelet Agent
The University of Hong Kong 2
Not applicableTemporarily Not AvailableNCT00839345
What this trial is testing

Clopidogrel Resistance and the Possibility of Its Affection

Who this might be right for
Coronary Artery Disease
Charles University, Czech Republic
Post-approval studies (Phase 4)UnknownNCT01557075
What this trial is testing

Aspirin Mono Therapy 12-months After Drug-eluting Stents Implantation

Who this might be right for
Drug-eluting Stent (DES)
Yonsei University 2,000
Not applicableNot Yet RecruitingNCT05650411
What this trial is testing

Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

Who this might be right for
Left Main Coronary Artery Stenosis
IGLESIAS Juan Fernando 828
Early research (Phase 1)UnknownNCT01388660
What this trial is testing

Pharmacokinetic Assessment of Simultaneous Administration of Clopidogrel and Aspirin

Who this might be right for
Coronary Artery Disease
Ajou University School of Medicine 60
Not applicableEnded earlyNCT03184805
What this trial is testing

STOPping Versus Continuing Antiplatelet Therapy During Noncardiac Surgery and Procedures After Next Generation Drug-eluting Stent Implantation

Who this might be right for
Coronary Artery Disease
Yonsei University 140
Not applicableStudy completedNCT00250380
What this trial is testing

The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)

Who this might be right for
Coronary DiseaseCerebral InfarctionIschemic Attack, Transient
Ministry of Health, Labour and Welfare, Japan 583
Testing effectiveness (Phase 2)Ended earlyNCT02227368
What this trial is testing

Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR

Who this might be right for
Peripheral Artery Disease (PAD)
AstraZeneca 40
Load More Results